Please provide your email address to receive an email when new articles are posted on . A subcutaneous implantable cardioverter defibrillator was noninferior to a transvenous ICD regarding major ...
In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
Traditionally implantable cardioverter defibrillators (ICDs) have been implanted transvenously by creating a pouch in the subclavicular area and gaining vascular access to the heart. This approach, ...
Patients with an indication for an implantable cardiac defibrillator for primary prevention of sudden cardiac death and a sharply reduced left ventricular ejection fraction of 35% or less safely ...
Implantable cardioverter-defibrillators (ICDs) reduce mortality in patients with increased risk of sudden cardiac death, but use of these devices has been limited by complications with the ...
Please provide your email address to receive an email when new articles are posted on . In a new study, patients reimplanted with a subcutaneous implantable cardioverter defibrillator after the ...
Subcutaneous implantable cardioverter-defibrillator (S-ICD) therapies represent a significant advance in the prevention of sudden cardiac death. By positioning both the generator and the lead entirely ...
People getting a subcutaneous implantable cardioverter-defibrillator (S-ICD) did fine skipping the defibrillation test after all, according to the PRAETORIAN-DFT randomized trial. In people randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results